MedVolumes.com Home


Domsys.com Safe Shopping Site

 
 
The Opportunity for Molecular Imaging in Clinical Trials

  Discount Medical Books > Clinical Trials > Item 134


< Previous Item Next Item >

Click here to buy The Opportunity for Molecular Imaging in Clinical Trials by  Chris Ingle, Marcel Warmerdam, and Claus Egge. The Opportunity for Molecular Imaging in Clinical Trials
by Chris Ingle, Marcel Warmerdam, and Claus Egge
0.0 out of 5 stars
List Price: $2,500.00
$2,500.00
At Amazon
on 10-16-2008.

More Info Buy It Now!

Do you have the free reader for this item?
Adobe Reader
  • Format: Adobe Reader PDF
  • Printable: Yes. This title is printable
  • Mac OS Compatible: OS 9.x or later
  • Windows Compatible: Yes
  • Handheld Compatible: Yes. Adobe Reader is available for PalmOS, Pocket PC, and Symbian OS.
  • Digital: 39 pages
  • Publisher: IDC Research January 10, 2007

    Product Description


    This Health Industry Insights report examines the current and future applications of molecular imaging (MI) in clinical drug development and identifies areas in which technological advances will increase and broaden the clinical use of MI.

    Noninvasive molecular measurements are becoming an integral part of rational decision making in the clinical evaluation of promising new drugs. MI techniques such as MRI, PET, CT, SPECT, ultrasound, and optical imaging are increasingly being used to connect evaluation of the molecular target in the lab to the metabolism of the compound in the body. MI offers a new level of understanding of how drug development candidates directly affect specific biological processes within the human body, providing insights early in the drug development process.

    With increasing information, however, comes increasing complexity in both instrumentation and subsequent analysis. Through better knowledge-based drug development, MI is expected to make the pharmaceutical development more efficient and more productive.

    "Noninvasive molecular imaging promises to transform the drug development process by providing direct visualization of the specific interactions of new drugs (both good and bad) within the human body," said Alan Louie, Ph.D., research director responsible for Health Industry Insights' research on technology solutions for drug discovery.

  • The Opportunity for Molecular Imaging in Clinical Trials
    Available from Amazon
    Price: $2,500.00
    Updated on 10-16-2008.
    More Info Buy It Now!

    < Previous Item Next Item >


    Search:
    Keywords:
    In Association with Amazon.com

    NOTICE: All product prices, availability, and specifications
    are subject to verification by their respective retailers.


    Copyright © 2008,Dominant Systems Corporation
    info@medvolumes.com         Privacy Policy
    Last Modified : 10-16-2008